NASDAQ: RLAYRelay Therapeutics Inc Stock Ownership - Who owns Relay Therapeutics?
Insider buying vs selling
Have Relay Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Peter Rahmer | CXO | 2026-07-28 | 748 | $18.61 | $13.92kSell |
| Thomas Catinazzo | CFO | 2026-07-28 | 1,459 | $18.61 | $27.15kSell |
| Donald A. Bergstrom | Pres | 2026-07-28 | 2,237 | $18.61 | $41.63kSell |
| Sanjiv Patel | President and CEO | 2026-07-07 | 48,199 | $19.58 | $943.74kSell |
| Donald A. Bergstrom | President RD | 2026-07-06 | 8,660 | $18.71 | $162.03kSell |
| Thomas Catinazzo | Chief Financial Officer | 2026-07-06 | 17,717 | $18.69 | $331.13kSell |
| Peter Rahmer | Chief Corporate Development Officer | 2026-06-30 | 50,000 | $19.09 | $954.50kSell |
| Peter Rahmer | Chief Corporate Development Officer | 2026-06-30 | 3,056 | $6.95 | $21.24kBuy |
| Sanjiv Patel | President and CEO | 2026-06-30 | 3,056 | $6.95 | $21.24kBuy |
| Thomas Catinazzo | Chief Financial Officer | 2026-06-22 | 61,563 | $5.22 | $321.36kBuy |
RLAY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RLAY insiders and whales buy or sell their stock.
RLAY Shareholders
What type of owners hold Relay Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Svf Pauling Cayman Ltd | 12.73% | 27,904,963 | $575.12M | Insider |
| Third Rock Ventures III LP | 4.81% | 10,551,115 | $217.46M | Insider |
| Picularium LLC | 1.50% | 3,281,253 | $67.63M | Insider |
| Sanjiv Patel | 0.99% | 2,177,349 | $44.88M | Insider |
| Mark Murcko | 0.45% | 996,952 | $20.55M | Insider |
| Alexandria Venture Investments LLC | 0.44% | 968,365 | $19.96M | Insider |
| Donald A. Bergstrom | 0.19% | 407,660 | $8.40M | Insider |
| Brian Adams | 0.17% | 371,472 | $7.66M | Insider |
| Alexis Borisy | 0.11% | 234,175 | $4.83M | Insider |
| Peter Rahmer | 0.10% | 228,165 | $4.70M | Insider |
RLAY vs Biotech Stocks
Relay Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.